Natalie Gukasyan
Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University
Data updated
Papers
Trials
Research Footprint
Natalie Gukasyan appears in 8 tracked papers (2020–2026), most studied alongside Psilocybin and LSD, across Depressive Disorders, Anxiety Disorders and Major Depressive Disorder (MDD).
Most-cited paper: Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up (407 citations).
Frequent co-authors: Frederick Barrett, Roland Griffiths and Sandeep Nayak.
Background & Research
Natalie Gukasyan is a psychiatrist and researcher in psychedelic medicine. She has been affiliated with the Johns Hopkins Center for Psychedelic and Consciousness Research, where she has studied psilocybin-assisted therapy, therapeutic alliance, adverse events, and predictors of psychedelic experience and clinical response. Her publications include work on psychedelic treatment for depression, eating disorders, and the effects of session facilitators and concomitant medications.
Key Impact
Natalie Gukasyan is a prominent clinical psychedelic researcher whose work spans psilocybin-assisted therapy, safety, set/setting, and treatment outcomes across mood and eating disorders.
Collaboration Network
12 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Natalie Gukasyan is associated with.